Key facts
- Pandia Health’s last known valuation is $24.0M (Mar 2025).
- It has raised $8.9M; the latest was Later Stage VC in Nov 2025.
- Notable investors include Impact Assets, Springboard Enterprises, StartX (US), Precursor Ventures, Allectus Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Pandia Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Pandia Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pandia Health
Operator of an online women's hormonal care platform intended to improve access to birth control and related treatments. The company's platform offers telemedicine consultations, prescription management, medication delivery, and personalized care plans, enabling women with convenient access to hormonal health services, ongoing medical support, and discreet delivery tailored to individual needs.
- Sector
- Healthcare
- HQ
- Sunnyvale, CA, United States
- Founded
- 2016
- Employees
- 35
- Website
- pandiahealth.com/
- Ownership
- Privately Held (backing)
Pandia Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pandia Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pandia Health in its N-PORT filings yet. We sweep new filings monthly.